Clinical Trial Update: Validation of Therapeutic Efficacy Targeting the Splicing Variants in Cystic Fibrosis and CFTR Pathologies [NA]

View source ↗

Summary

Clinical trial evaluating therapies targeting splicing variants in cystic fibrosis and CFTR-related pathologies has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Cystic Fibrosis, CFTR Gene Mutation | NA | Status: TERMINATED